Allan McLay Fowler

This profile gathers the share dealings of Allan McLay Fowler in CanniMed Therapeutics Inc. Over a trading history stretching from 7 September 2017 to 8 February 2018, the count stands at 3 filings.

Every open-market trade on record is a sale: 1 sale worth €656k. The rest of the record consists of 1 option exercise. 2018 to date brings no purchases and 1 sale.

The newest entry dates from 12 February 2018: an option exercise of €199k, in CanniMed Therapeutics Inc. Typically, a trade is published a median of 4 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.